IOI. K. Oleynik

I. K. Oleynik

*This is an algorithmically generated author record based on publicly available information.

I. K. Oleynik has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Anastasiya G. Samoylova

    National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Ministry of Health of the Russian Federation

    1 shared publication
  • Anna Evgenievna Panova

    National Medical Research Center of Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation

    1 shared publication
  • Platon Ivanovich Eliseev

    National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health

    1 shared publication
  • А. Г. Самойлова

    ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФ

    1 shared publication
  • А. Е. Панова

    ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФ

    1 shared publication
  • И. К. Олейник

    ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФ

    1 shared publication

Latest Publications

  • Open Access

    Phenotypic and Molecular Genetic Resistance of Mycobacterium tuberculosis to Fluoroquinolones: A Literature Review

    by I. K. Oleynik, P. I. Eliseev, A. E. Panova, A. G. Samoilova, И. К. Олейник, П. И. Елисеев, А. Е. Панова, А. Г. Самойлова

    Fluoroquinolones are essential drugs for the treatment of drug-resistant tuberculosis; however, the rise in resistance to these agents significantly reduces treatment efficacy. This review summarizes current data on the molecular genetic and phenotypic mechanisms of Mycobacterium tuberculosis resistance to fluoroquinolones. Particular attention is focused on mutations in the gyrA and gyrB genes encoding DNA gyrase, the primary target of fluoroquinolones. Mutations within the QRDR of gyrA are the major determinants of resistance and are associated with an increase in the minimum inhibitory concentrations of fluoroquinolones. This review examines the role of alternative resistance mechanisms, including efflux pump systems and glpK -associated adaptations, as well as the importance of the WHO Catalogue of Mutations for variant interpretation. The integration of phenotypic and molecular diagnostic approaches is essential for the effective detection and control of drug-resistant tuberculosis.